Spanish Preanalytical Quality Monitoring Program (SEQC), an overview of 12 years' experience

Llopis, M. A. ; Bauça, J. M. ; Barba, N. ; Álvarez, V. ; Ventura, M. ; Ibarz, M. ; Gómez-Rioja, R. ; Marzana, I. ; Puente, J. J. ; Segovia, M. ; Martinez, D. ; Alsina, M. J.

Resumen: Preanalytical variables, such as sample collection, handling and transport, may affect patient results. Preanalytical phase quality monitoring should be established in order to minimize laboratory errors and improve patient safety. A retrospective study (2001-2013) of the results obtained through the Spanish Society of Clinical Biochemistry and Molecular Pathology (SEQC) External quality assessment (preanalytical phase) was performed to summarize data regarding the main factors affecting preanalytical phase quality. Our aim was to compare data from 2006 to 2013 with a previously published manuscript assessing the 2001-2005 period. A significant decrease in rejection rates was observed both for blood and urine samples. For serum samples, the most frequent rejection causes in the first period were non-received samples (37.5%), hemolysis (29.3%) and clotted samples (14.4%). Conversely, in the second period, hemolysis was the main rejection cause (36.2%), followed by non-received samples (34.5%) and clotted samples (11.1%). For urine samples, the main rejection cause overall was a non-received sample (up to 86.1% of cases in the second period, and 81.6% in the first). For blood samples with anticoagulant, the number of rejections also decreased. While plasma-citrate-ESR still showed the highest percentages of rejections (0.980% vs. 1.473%, p<0.001), the lowest corresponded to whole-blood EDTA (0.296% vs. 0.381%, p<0.001). For the majority of sample types, a decrease in preanalytical errors was confirmed. Improvements in organization, implementation of standardized procedures in the preanalytical phase, and participation in a Spanish external quality assessment scheme may have notably contributed to error reduction in this phase.

Idioma: Inglés

DOI: 10.1515/cclm-2016-0382

Año: 2017

Publicado en: Clinical Chemistry and Laboratory Medicine 55, 4 (2017), 530-538
ISSN: 1434-6621

Factor impacto JCR: 3.556 (2017)

Categ. JCR: MEDICAL LABORATORY TECHNOLOGY rank: 7 / 30 = 0.233 (2017) - Q1 - T1

Factor impacto SCIMAGO: 1.114 - Biochemistry (medical) (Q1) - Medicine (miscellaneous) (Q1) - Clinical Biochemistry (Q2)

Tipo y forma: Artículo (Versión definitiva)